Literature DB >> 26915269

The Genomics, Epigenomics, and Transcriptomics of HPV-Associated Oropharyngeal Cancer--Understanding the Basis of a Rapidly Evolving Disease.

M Lechner1, T R Fenton2.   

Abstract

Human papillomavirus (HPV) has been shown to represent a major independent risk factor for head and neck squamous cell cancer, in particular for oropharyngeal carcinoma. This type of cancer is rapidly evolving in the Western world, with rising trends particularly in the young, and represents a distinct epidemiological, clinical, and molecular entity. It is the aim of this review to give a detailed description of genomic, epigenomic, transcriptomic, and posttranscriptional changes that underlie the phenotype of this deadly disease. The review will also link these changes and examine what is known about the interactions between the host genome and viral genome, and investigate changes specific for the viral genome. These data are then integrated into an updated model of HPV-induced head and neck carcinogenesis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Epigenetics; Genomics; HNSCC; HPV; Methylation; Oropharynx; Papillomavirus; SCC

Mesh:

Substances:

Year:  2016        PMID: 26915269     DOI: 10.1016/bs.adgen.2015.12.001

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  15 in total

1.  Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.

Authors:  Ankur Chakravarthy; Stephen Henderson; Stephen M Thirdborough; Christian H Ottensmeier; Xiaoping Su; Matt Lechner; Andrew Feber; Gareth J Thomas; Tim R Fenton
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

Review 2.  TMEM16A as a potential treatment target for head and neck cancer.

Authors:  Kohei Okuyama; Souichi Yanamoto
Journal:  J Exp Clin Cancer Res       Date:  2022-06-07

3.  General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival.

Authors:  Hans Jørgen Aarstad; Arild Andrè Østhus; Helene Hersvik Aarstad; Stein Lybak; Anne Kari Hersvik Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-20       Impact factor: 2.503

4.  Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5'-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients.

Authors:  Timo J Vogt; Heidrun Gevensleben; Jörn Dietrich; Glen Kristiansen; Friedrich Bootz; Jennifer Landsberg; Diane Goltz; Dimo Dietrich
Journal:  Oncoimmunology       Date:  2018-04-18       Impact factor: 8.110

5.  PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.

Authors:  Diane Goltz; Heidrun Gevensleben; Joern Dietrich; Friederike Schroeck; Luka de Vos; Freya Droege; Glen Kristiansen; Andreas Schroeck; Jennifer Landsberg; Friedrich Bootz; Dimo Dietrich
Journal:  Oncotarget       Date:  2017-06-20

6.  Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma.

Authors:  Luca Sigalotti; Elisabetta Fratta; Carlo Furlan; Jerry Polesel; Luigi Barzan; Giovanni Franchin; Sandro Sulfaro; Salvatore Romeo; Francesca Colizzi; Aurora Rizzo; Vittorio Baggio; Vittorio Giacomarra; Angelo Paolo Dei Tos; Paolo Boscolo-Rizzo; Emanuela Vaccher; Riccardo Dolcetti
Journal:  Clin Epigenetics       Date:  2017-05-30       Impact factor: 6.551

7.  Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.

Authors:  Verena Sailer; Heidrun Gevensleben; Joern Dietrich; Diane Goltz; Glen Kristiansen; Friedrich Bootz; Dimo Dietrich
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

8.  The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies.

Authors:  Zhisen Shen; Chongchang Zhou; Jinyun Li; Hongxia Deng; Qun Li; Jian Wang
Journal:  Onco Targets Ther       Date:  2016-10-31       Impact factor: 4.147

9.  PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.

Authors:  Verena Sailer; Emily Eva Holmes; Heidrun Gevensleben; Diane Goltz; Freya Dröge; Alina Franzen; Jörn Dietrich; Glen Kristiansen; Friedrich Bootz; Andreas Schröck; Dimo Dietrich
Journal:  Clin Epigenetics       Date:  2017-02-02       Impact factor: 6.551

10.  Detection of PIK3CA Gene Mutation in Head and Neck Squamous Cell Carcinoma Using Droplet Digital PCR and RT-qPCR.

Authors:  Edyta M Borkowska; Magda Barańska; Magdalena Kowalczyk; Wioletta Pietruszewska
Journal:  Biomolecules       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.